(Q35041945)

6 August 2017

1 reference

title

Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity (English)

1 reference

6 August 2017

0 references

1 reference

Lucio G Costa

1

1 reference

6 August 2017

Rebecca J Richter

2

1 reference

6 August 2017

Wan-Fen Li

3

1 reference

6 August 2017

Toby Cole

4

1 reference

6 August 2017

Marina Guizzetti

5

1 reference

6 August 2017

Clement E Furlong

6

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

1-12

1 reference

The influence of age on the toxicity and metabolism of methyl parathion and parathion in male and female rats

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Polymorphisms in the human paraoxonase (PON1) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Gene therapy to prevent organophosphate intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Purification of rabbit and human serum paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

The molecular basis of the human serum paraoxonase activity polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Serum paraoxonase status: a major factor in determining resistance to organophosphates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase protects against chlorpyrifos toxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Organophosphate detoxication potential of various rat tissues via A-esterase and aliesterase activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Environmental risk factors and Parkinson's disease: a metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

AGE VARIATION IN PLASMA ARYLESTERASE ACTIVITY IN CHILDREN

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500210148315

Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks

21 January 2018

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/13547500210148315

Sarin poisoning on Tokyo subway

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/13547500210148315

Identifiers

DOI

10.1080/13547500210148315

1 reference

6 August 2017

1 reference